Answers are grounded in this paper and cite their sources.
Objective To investigate whether human umbilical cord mesenchymal stem cells-derived exosomes could inhibit pancreatic ductal adenocarcinoma progression. Methods The human umbilical cord derived-mesenchymal stem cells (huc-MSCs) loaded with microRNA (miRNA, miR)-145-5p mimics and negative control miRNA were added to pancreatic ductal adenocarcinoma (PDAC) cells. The proliferative activity and invasion abilities of BxPC3 and PANC-1 cells were measured by cell counting kit-8 (CCK-8) and Transwell assays. The cell cycle and cell apoptosis were detected by flow cytometry analysis. The expression levels of Smad3 were detected by Western blotting. Results HucMSC exosomes were isolated and purified from the hucMSC-conditioned medium by ultracentrifugation. HucMSC exosomes had a characteristic 'saucer-like’ morphology with diameters that ranged from 52.5 nm to 185.5 nm, with an average of 119 nm and the concentration of hucMSC exosomes was 400 Particles/ml. Further results showed positive expression of exosomal markers, such as CD9 and CD81. The results of cell proliferation showed that the absorbance value of BxPC3 and PANC-1 cells in 145-exo group was significantly lower than that of the NC-exo group after 4 days [(2.681±0.049) vs. (3.683±0.003), t=20.460, P<0.05; (2.646±0.116) vs. (3.450±0.112), t=4.992, P<0.05]. The results of Transwell assays showed that the number of metastatic ceils in the 145-exo group was significantly decreased compared to the NC-exo group [(68.200±3.262) cells vs. (104.800±2.177) cells, t=9.333, P<0.05; (83.000±3.493) cells vs. (146.200±4.432) cells, t=11.200, P<0.05]. Flow cytometric analysis revealed that 145-exo group caused an increase in the percentage of the cells in the G0/G1 stage of the cell cycle compared to the NC-exo group [(43.030±1.060)% vs. (31.730±0.843)%, t=8.346, P<0.05)]. Flow cytometric analysis revealed that 145-exo group increase in apoptotic cells, relative to NC-exo group [(10.970±0.405)% vs. (6.863±0.099)%, t=9.830, P<0.05; (2.400±0.166)% vs. (1.513±0.045)%, t=5.167, P<0.05]. The expression of Smad3 protein in 145-exo group was reduced by 38.0% and 37.4%, respectively (t=6.362, P<0.05; t=11.430, P<0.05). Conclusion HucMSCs-exo can effectively deliver miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression, which may be related to downregulation of Smad3 expression.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: